A systematic review highlights the potential of genomic tests in prostate cancer treatment decisions but calls for more data on their effectiveness.

TUESDAY, Jan. 21, 2025 -- For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk...

TUESDAY, Jan. 21, 2025 -- For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk...

A new review led by researchers at Moffitt Cancer Centre, USA, assessed how three genomic tests — Decipher, Oncotype DX Genomic Prostate Score...

Genomic tests are revolutionizing prostate cancer care, enabling precise, personalized treatment tailored to each patient.

Researchers conducted a review examining how three genomic tests-Decipher, Oncotype DX Genomic Prostate Score (GPS), and Prolaris-can aid doctors in...

Data analysis from a randomised clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham Cancer Center, USA, found...

By Chidinma Ewunonu-AlukoProf. Jesse Otegbayo, Chief Medical Director (CMD), University College Hospital (UCH), Ibadan, has advised Nigerians to...

A recent analysis has revealed a strong connection between physical strength, fitness, and a longer life for people with cancer. The study, published...

THURSDAY, Jan. 23, 2025 -- For patients diagnosed with cancer, high muscle strength and cardiorespiratory fitness (CRF) are associated with a reduced...